title: Neuroendocrine cancer. Closing the GAPP on predicting metastases.
abstract: A promising grading system to predict metastasis in patients with phaeochromocytoma and paraganglioma assigns risk according to selected histological and other criteria. Such risk stratification might be useful for personalized management and screening programmes, as it could limit the costs of follow-up and reduce the risk of disseminated disease.
authors.affiliation: Institute of Clinical Chemistry & Laboratory Medicine and Department of Medicine III, University Hospital, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
authors.forename: Graeme
authors.initials: G
authors.lastname: Eisenhofer
authors.affiliation: Department of Pathology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
authors.forename: Arthur S
authors.initials: AS
authors.lastname: Tischler
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D010235:Paraganglioma / Q000473:pathology*; D010673:Pheochromocytoma / Q000556:secondary*; D013385:Succinate Dehydrogenase / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D013385:Succinate Dehydrogenase